Biote Corp. (BTMD)
BTMD trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.04
-8.77% on the day
Market cap
$37.4M
Nano cap
Revenue · 2025
$192.2M
-2.5% on 2024
Net income · 2025
$27.0M
14.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BTMD on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001819253 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $192.2M |
| Net income | $27.0M |
| Operating income | $35.6M |
| Net margin | 14.1% |
| Operating margin | 18.5% |
| Revenue growth | -2.5% |
| Cash | $24.1M |
| Total assets | $107.6M |
| P/E (computed) | 1.4× |
| P/S (computed) | 0.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2025-04-09 |
| Latest annual report | 10-K | 2026-03-13 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-02 |
Source: SEC EDGAR submissions feed, 410 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ISPR | Ispire Technology Inc. | $1.45 | -1.36% | $83.7M |
| FTLF | FitLife Brands Inc. | $9.07 | -1.73% | $85.2M |
| MTEX | Mannatech Incorporated | $7.56 | -2.95% | $14.6M |
| BON | Bon Natural Life Limited | $1.12 | -0.76% | $9.1M |
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
| NAII | Natural Alternatives International Inc. | $1.15 | -5.74% | $7.2M |
| NAGE | Niagen Bioscience Inc. | $2.58 | -1.90% | $204.1M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.29 | -1.38% | $265.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier